CorMedix appoints Elizabeth Hurlburt as Chief Operating and Commercial Officer; Michael Seckler departs

CorMedix Inc.

Elizabeth Hurlburt, previously COO, appointed to newly created role of Chief Operating and Commercial Officer, effective June 29, 2026.
Hurlburt will oversee commercial, medical affairs, regulatory, and clinical functions, reporting to Chairman & CEO Joseph Todisco.
Michael Seckler has left the Company as part of the leadership restructuring.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.